GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 195 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $594,000 | +1.2% | 18,600 | +9.7% | 0.38% | +20.6% |
| Q1 2022 | $587,000 | +35.6% | 16,950 | +14.5% | 0.32% | +29.1% |
| Q4 2021 | $433,000 | +15.5% | 14,800 | +0.7% | 0.24% | +7.5% |
| Q3 2021 | $375,000 | +69.7% | 14,700 | +133.3% | 0.23% | +68.1% |
| Q2 2021 | $221,000 | +370.2% | 6,300 | +447.8% | 0.14% | +365.5% |
| Q1 2021 | $47,000 | +261.5% | 1,150 | +283.3% | 0.03% | +222.2% |
| Q4 2020 | $13,000 | – | 300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 356,069 | $16,094,000 | 8.69% |
| Perceptive Advisors | 4,828,910 | $218,266,000 | 5.72% |
| Grace Capital | 98,939 | $13,970,000 | 5.34% |
| GREAT POINT PARTNERS LLC | 770,400 | $34,822,000 | 4.83% |
| Camber Capital Management LP | 2,200,000 | $99,440,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 602,200 | $27,219,000 | 3.77% |
| Ghost Tree Capital, LLC | 242,000 | $10,938,000 | 3.22% |
| Casdin Capital, LLC | 480,000 | $21,696,000 | 3.03% |
| NEXTHERA CAPITAL LP | 404,092 | $18,265,000 | 2.83% |
| Asymmetry Capital Management, L.P. | 49,355 | $2,231,000 | 2.19% |